杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/11/28 | 2,407 | 2,409 | 2,368 | 2,383 | -42 | -1.7% | 226,700 |
2016/11/25 | 2,431 | 2,436 | 2,415 | 2,425 | +11 | +0.5% | 99,100 |
2016/11/24 | 2,456 | 2,456 | 2,414 | 2,414 | -20 | -0.8% | 116,700 |
2016/11/22 | 2,428 | 2,447 | 2,411 | 2,434 | +1 | ±0% | 207,300 |
2016/11/21 | 2,418 | 2,439 | 2,402 | 2,433 | +17 | +0.7% | 131,600 |
2016/11/18 | 2,455 | 2,459 | 2,402 | 2,416 | -42 | -1.7% | 161,000 |
2016/11/17 | 2,425 | 2,469 | 2,424 | 2,458 | +23 | +0.9% | 114,400 |
2016/11/16 | 2,435 | 2,439 | 2,407 | 2,435 | +5 | +0.2% | 131,700 |
2016/11/15 | 2,439 | 2,445 | 2,412 | 2,430 | +1 | ±0% | 152,300 |
2016/11/14 | 2,434 | 2,455 | 2,412 | 2,429 | +17 | +0.7% | 136,100 |
2016/11/11 | 2,431 | 2,448 | 2,408 | 2,412 | +12 | +0.5% | 197,000 |
2016/11/10 | 2,360 | 2,402 | 2,326 | 2,400 | +151 | +6.7% | 272,200 |
2016/11/09 | 2,299 | 2,325 | 2,204 | 2,249 | -28 | -1.2% | 318,900 |
2016/11/08 | 2,259 | 2,287 | 2,259 | 2,277 | +18 | +0.8% | 194,700 |
2016/11/07 | 2,290 | 2,315 | 2,189 | 2,259 | +16 | +0.7% | 286,500 |
2016/11/04 | 2,266 | 2,276 | 2,227 | 2,243 | -56 | -2.4% | 140,900 |
2016/11/02 | 2,311 | 2,317 | 2,277 | 2,299 | -24 | -1% | 133,800 |
2016/11/01 | 2,332 | 2,334 | 2,302 | 2,323 | -27 | -1.1% | 142,400 |
2016/10/31 | 2,328 | 2,353 | 2,299 | 2,350 | -12 | -0.5% | 262,100 |
2016/10/28 | 2,305 | 2,378 | 2,305 | 2,362 | +72 | +3.1% | 390,200 |
2016/10/27 | 2,286 | 2,309 | 2,265 | 2,290 | -22 | -1% | 199,900 |
2016/10/26 | 2,280 | 2,319 | 2,273 | 2,312 | +4 | +0.2% | 199,800 |
2016/10/25 | 2,307 | 2,318 | 2,299 | 2,308 | ±0 | ±0% | 114,000 |
2016/10/24 | 2,283 | 2,310 | 2,277 | 2,308 | +21 | +0.9% | 102,500 |
2016/10/21 | 2,314 | 2,314 | 2,282 | 2,287 | -20 | -0.9% | 125,500 |
2016/10/20 | 2,278 | 2,308 | 2,270 | 2,307 | +16 | +0.7% | 154,200 |
2016/10/19 | 2,308 | 2,311 | 2,278 | 2,291 | -32 | -1.4% | 142,000 |
2016/10/18 | 2,288 | 2,340 | 2,285 | 2,323 | +31 | +1.4% | 150,500 |
2016/10/17 | 2,271 | 2,292 | 2,253 | 2,292 | +5 | +0.2% | 97,200 |
2016/10/14 | 2,297 | 2,311 | 2,277 | 2,287 | -5 | -0.2% | 129,700 |
2016/10/13 | 2,289 | 2,296 | 2,269 | 2,292 | +1 | ±0% | 169,700 |
2016/10/12 | 2,261 | 2,304 | 2,261 | 2,291 | -1 | ±0% | 150,100 |
2016/10/11 | 2,285 | 2,299 | 2,271 | 2,292 | -2 | -0.1% | 147,800 |
2016/10/07 | 2,289 | 2,298 | 2,280 | 2,294 | -2 | -0.1% | 94,300 |
2016/10/06 | 2,302 | 2,305 | 2,271 | 2,296 | -4 | -0.2% | 139,600 |
2016/10/05 | 2,326 | 2,327 | 2,289 | 2,300 | -17 | -0.7% | 193,400 |
2016/10/04 | 2,314 | 2,329 | 2,289 | 2,317 | +7 | +0.3% | 195,400 |
2016/10/03 | 2,307 | 2,318 | 2,293 | 2,310 | +31 | +1.4% | 97,700 |
2016/09/30 | 2,262 | 2,305 | 2,260 | 2,279 | -54 | -2.3% | 152,200 |
2016/09/29 | 2,341 | 2,359 | 2,307 | 2,333 | +42 | +1.8% | 150,200 |
2016/09/28 | 2,351 | 2,351 | 2,273 | 2,291 | -44 | -1.9% | 260,500 |
2016/09/27 | 2,245 | 2,335 | 2,230 | 2,335 | +92 | +4.1% | 189,700 |
2016/09/26 | 2,269 | 2,271 | 2,235 | 2,243 | -27 | -1.2% | 127,400 |
2016/09/23 | 2,269 | 2,286 | 2,244 | 2,270 | +11 | +0.5% | 161,200 |
2016/09/21 | 2,193 | 2,265 | 2,168 | 2,259 | +66 | +3% | 135,800 |
2016/09/20 | 2,160 | 2,205 | 2,152 | 2,193 | +9 | +0.4% | 199,400 |
2016/09/16 | 2,175 | 2,200 | 2,175 | 2,184 | +17 | +0.8% | 194,600 |
2016/09/15 | 2,178 | 2,183 | 2,161 | 2,167 | -12 | -0.6% | 84,700 |
2016/09/14 | 2,180 | 2,201 | 2,176 | 2,179 | -17 | -0.8% | 67,400 |
2016/09/13 | 2,220 | 2,241 | 2,179 | 2,196 | +21 | +1% | 110,700 |
2051~
2100
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 147,600円 | +3.2% | +4.5% | 3.52% | 16.96倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ジーエヌアイ | 222,700円 | +21.7% | +999.9% | 0.00% | 9.27倍 | 3.07倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 306,500円 | +3.0% | +27.5% | 2.61% | 19.40倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 225,300円 | +0.4% | -8.4% | 2.35% | 28.92倍 | 1.64倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 85,000円 | +22.8% | - | 0.00% | 69.44倍 | 1.12倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム